Prime Global is absolutely delighted to be listed in the top ten of the Alantra Pharma Fast 50; the third consecutive year we have been included in the top ten! This demonstrates and reinforces our sector-leading, sustainable organic growth.
Graeme Peterson, CEO, said: “I am humbled and proud to be included in the Alantra Pharma Fast 50 for the third year running. Our people’s commitment to hard work with incredible talent and creativity has led to sustained, high-level growth over the past three years. It’s great that this has been independently acknowledged by our inclusion in this list.”
Alantra is a global investment banking, credit portfolio advisory and alternative asset management firm focusing on the mid-market with offices across Europe, the US, Latin America and Asia. The Alantra Pharma Fast 50 is their annual ranking of the 50 fastest-growing privately owned pharma and pharma service companies in the UK.
Our inclusion by Alantra comes just shortly after the announcement that we have ranked on the Sunday Times Virgin Atlantic Fast Track 100 for the past three years. This league table ranks Britain’s top 100 private companies with the fastest growing sales over their latest three years.
These accolades illustrate the exceptional ongoing organic growth experienced by Prime Global. High points in the past year include the early 2020 launch of Prime Access, a Market Access consultancy, and the June 2020 launch of new strategic consultancy IRIS (Insights-Research-Innovation-Strategy).
View the Alantra Pharma Fast 50 here: https://www.alantra.com/alantra-pharma-fast-50/